Global Deaths From Melanoma Predicted to Increase 50% by 2040
Melanoma cases were almost 10 times higher in high Human Development Index countries than in low.
ICYMI: Atopic Dermatitis Insight at SPD
Two poster presentations at this year’s Society for Pediatric Dermatology Meeting delve into the psychological impact of the condition and a new option for management.
Chronic Immune-Related Adverse Events Common in Anti-PD-1 Therapy for Melanoma
Endocrine toxic effects were more likely than nonendocrine to become chronic and continue at last follow-up.
Superficial and Deep Midfacial Injections Offer Significant Results
Researchers found no statistically significant difference between injection techniques.
Adherence to Apremilast Treatment for Psoriasis Similar Regardless of Method of Visit
Apremilast treatment for psoriasis and psoriatic arthritis can be managed effectively through telehealth visits.
SFA-002 Phase 1b Trial Shows Positive Results for Treatment of Psoriasis
In the cohort trial, 85% of patients showed an improvement of more than 50 on PASI.
Epidermal AXL Expression Lower in Psoriatic Skin
The findings highlight new data on AXL expression in inflammatory diseases.
Ceramide-Containing Sunscreen Improves Skin Hydration
After 4 weeks of daily use, 92% of participants showed an improvement in skin hydration.
Rajani Katta, MD, Discusses the Science Between the Skin/Diet Link
Research continues to show that food plays a large role in skin diseases.
Nonsurgical Treatment for Nonmelanoma Skin Cancer Exhibits 99% Cure Rate
Image-Guided Superficial Radiation Therapy kills cancer cells without surgery.
Christopher G. Bunick, MD, PhD, Receives 2023 Research Scholar Award
The American Acne and Rosacea Society selected Bunick’s research on tetracycline-class compounds for the award.
Follicular Unit Excision Successful in Treating Acne Keloidalis Nuchae
The treated areas remained clear up to 18 months after treatment with follicular unit excision.
Infection Risk Lower With IL-23i and IL-17i Than With TNFi in Psoriasis
Patients with psoriasis treated with IL-23i and IL-17i had a decreased risk of developing pneumonia, otitis media, and upper respiratory tract infections.
Actual Age Test App Adds Skin Health Evaluation
Longevity Playbook helps individuals understand how their lifestyle choices affect signs of aging.
Novel Serum Improves Overall Skin Quality With No Adverse Events
All participants showed fewer fine lines by the end of the 12-week study.
Careers in Medicine Event Inspires Young Women to Explore the Medical Field
Attendees learned about a variety of professions in healthcare and how to prepare for them.
Research Grant Will Expand Understanding of Dermatological Issues Among Skin of Color
The Sanofi-Regeneron Diversity, Equity, and Inclusion Mid-Career Award applications will open September 15.
Severity of Atopic Dermatitis Increases Disease Burden
Among children and adolescents with atopic dermatitis, higher severity led to more school absences.
Breakthrough Therapy Designation Granted to SD-101 for Treatment of Epidermolysis Bullosa
The topical cream is the first epidermolysis bullosa treatment to receive Breakthrough Therapy designation from the FDA.
Nivolumab Approved for Treatment of Stage IIB/IIC Melanoma in Europe
Risk of recurrence or death was reduced by 58% compared to placebo.
Newly Approved Device Improves Periorbital Wrinkles With Minimal Down Time
The Tixel by Sentient eliminates the need for eye protection for patients and providers.
Neck Cream With Retinol, Tripeptide, and Glaucine Increased Collagen
All participants saw an improvement in skin appearance and texture after treatment.
Skin Microbiota Changes With Sun Exposure
After a minimum 7-day vacation, participants with the highest ultraviolet radiation exposure experienced a decrease in Proteobacteria.
Subcutaneous Nodules Misdiagnosed as Pilomatricoma
When children present with nodules, several diagnoses should be considered, including pilomatricoma, vascular tumors, and fibrous tumors.
Study: Acne a Common Side Effect of Atopic Dermatitis Treatment
Acne was mild to moderate in severity and successfully managed with topical or oral treatments.
Patients Grade Disease Severity Higher Than Physicians
Patient and physician demographics were not significantly associated with discordance.
Patients With Pemphigus Vulgaris Given Rituximab did not Experience More Severe COVID-19
Total dose and number of cycles of rituximab were not associated with duration or severity of COVID-19 disease.
31-Gene Expression Profile Test Accurately Classified Risk of Death From Melanoma
Patients with the DecisionDx-Melanoma 31-gene expression profile test had a 29% lower melanoma-specific survival mortality.
Patients With Blood Type A had a Higher Incidence of Severe Acne
ABO blood type appeared to be a factor in severity of acne vulgaris.
VP-315 Effective in Clearing Basal Cell Carcinoma Lesions
Most of the patients receiving the non-surgical treatment experienced a complete clearing of tumors.